Cargando…
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone
BACKGROUND: Although atrial fibrillation ablation is increasingly used for rhythm control therapy, antiarrhythmic drugs (AADs) are commonly used, either alone or in combination with ablation. The effectiveness of AADs is highly variable. Previous work from our group suggests that alterations in atri...
Autores principales: | Holmes, Andrew P., Saxena, Priyanka, Kabir, S. Nashitha, O’Shea, Christopher, Kuhlmann, Stefan M., Gupta, Suranjana, Fobian, Dannie, Apicella, Clara, O’Reilly, Molly, Syeda, Fahima, Reyat, Jasmeet S., Smith, Godfrey L., Workman, Antony J., Pavlovic, Davor, Fabritz, Larissa, Kirchhof, Paulus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259123/ https://www.ncbi.nlm.nih.gov/pubmed/33737232 http://dx.doi.org/10.1016/j.hrthm.2021.03.016 |
Ejemplares similares
-
Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide
por: O’Reilly, Molly, et al.
Publicado: (2022) -
Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol
por: Kojić, Dejan, et al.
Publicado: (2023) -
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
por: Reyat, Jasmeet S., et al.
Publicado: (2020) -
PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017) -
The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy
por: Pavlovic, Davor, et al.
Publicado: (2018)